NDC Code(s) : 69336-823-30
Packager : Sterling-Knight Pharmaceuticals, LLC

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Tetravex
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69336-823
Route of Administration DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TETRACAINE HYDROCHLORIDE(UNII: 5NF5D4OPCI)
(TETRACAINE - UNII:0619F35CGV) 		TETRACAINE HYDROCHLORIDE20 mg in 1000 g
Inactive Ingredients
Ingredient Name Strength
WATER(UNII: 059QF0KO0R)
BOVINE TYPE I COLLAGEN(UNII: FHJ3ATL51C)
aloe vera leaf(UNII: ZY81Z83H0X)
SODIUM ALGINATE(UNII: C269C4G2ZQ)
GLYCERIN(UNII: PDC6A3C0OX)
CETYL HYDROXYETHYLCELLULOSE (350000 MW)(UNII: T7SWE4S2TT)
TRIETHANOLAMINE BENZOATE(UNII: M3EN4GC19W)
BENZETHONIUM CHLORIDE(UNII: PH41D05744)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:69336-823-3028.33 g in 1 TUBE Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
premarket notification K020540 06/06/2018

PRINCIPAL DISPLAY PANEL

Distributed By: Sterling-Knight Pharmaceuticals, LLC
Ripley, MS 38663

tetra